A treatment for the most common cause of dwarfism met its goal of increasing height in a pivotal study, the drug’s maker said Monday, setting the stage for Food and Drug Administration approval. The ...
A genetic disorder that slows bone growth and leads to dwarfism now has an approved drug, a biologic therapy developed by BioMarin Pharmaceutical. The European Commission decision announced Friday ...
A novel drug for the most common cause of dwarfism accelerated children’s growth in a small but closely watched clinical trial, the company BridgeBio said Monday, advancing the latest treatment in ...
Hulu's "Good American Family" tells the tragic story of Natalia Grace, a Ukrainian girl born with dwarfism who was adopted by an American family when she was seven. Natalia specifically has ...
An experimental drug increased growth rates in children with dwarfism, according to a new study. The four-year phase 2 trial was conducted at centers in the United States, France, United Kingdom and ...
Diastrophic dysplasia (DTD) is a type of skeletal dysplasia, a group of conditions often resulting in dwarfism. DTD may cause a person to have short stature and very short arms and legs. DTD is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback